The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Paracetamol for low back pain
Open accessAbstract
BACKGROUND: Analgesic medication is the most frequently prescribed treatment for low back pain (LBP), of which paracetamol (acetaminophen) is recommended as the first choice medication. However, there is uncertainty about the efficacy of paracetamol for LBP. OBJECTIVES: To investigate the efficacy and safety of paracetamol for non-specific LBP. SEARCH METHODS: We conducted searches on the Cochrane Central Register of Controlled Trials (CENTRAL, which includes the Back and Neck Review Group trials register), MEDLINE, EMBASE, CINAHL, AMED, Web of Science, LILACS, and IPA from their inception to 7 August 2015. We also searched the reference lists of eligible papers and trial registry websites (WHO ICTRP and ClinicalTrials.gov). SELECTION CRITERIA: We only considered randomised trials comparing the efficacy of paracetamol with placebo for non-specific LBP. The primary outcomes were pain and disability. We also investigated quality of life, function, adverse effects, global impression of recovery, sleep quality, patient adherence, and use of rescue medication as secondary outcomes. DATA COLLECTION AND ANALYSIS: Two review authors independently performed the data extraction and assessed risk of bias in the included studies. We also evaluated the quality of evidence using the GRADE approach. We converted scales for pain intensity to a common 0 to 100 scale. We quantified treatment effects using mean difference for continuous outcomes and risk ratios for dichotomous outcomes. We used effect sizes and 95% confidence intervals as a measure of treatment effect for the primary outcomes. When the treatment effects were smaller than 9 points on a 0 to 100 scale, we considered the effect as small and not clinically important. MAIN RESULTS: Our searches retrieved 4449 records, of which three trials were included in the review (n = 1825 participants), and two trials were included in the meta-analysis. For acute LBP, there is high-quality evidence for no difference between paracetamol (4 g per day) and placebo at 1 week (immediate term), 2 weeks, 4 weeks, and 12 weeks (short term) for the primary outcomes. There is high-quality evidence that paracetamol has no effect on quality of life, function, global impression of recovery, and sleep quality for all included time periods. There were also no significant differences between paracetamol and placebo for adverse events, patient adherence, or use of rescue medication. For chronic LBP, there is very low-quality evidence (based on a trial that has been retracted) for no effect of paracetamol (1 g single intravenous dose) on immediate pain reduction. Finally, no trials were identified evaluating patients with subacute LBP. AUTHORS' CONCLUSIONS: We found that paracetamol does not produce better outcomes than placebo for people with acute LBP, and it is uncertain if it has any effect on chronic LBP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
GRADE guidelines 6. Rating the quality of evidence—imprecision
Guyatt, G. H., Oxman, A. D., Kunz, R., Brozek, J., Alonso-Coello, P., Rind, D., Devereaux, P. J., Montori, V. M., Freyschuss, B., Vist, G., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.01.012 · Cited by 2,693
Chapter 4 European guidelines for the management of chronic nonspecific low back pain
Airaksinen, O., Brox, J. I., Cedraschi, C., Hildebrandt, J., Klaber-Moffett, J., Kovacs, F., Mannion, A. F., Reis, S., Staal, J. B., Ursin, H., et al. (2006) · European Spine Journal · doi:10.1007/s00586-006-1072-1 · Cited by 2,594
Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group
van Tulder, M., Furlan, A., Bombardier, C., & Bouter, L. (2003) · Spine · doi:10.1097/01.brs.0000065484.95996.af · Cited by 2,180
Ostelo, R. W. J. G., Deyo, R. A., Stratford, P., Waddell, G., Croft, P., Von Korff, M., Bouter, L. M., & de Vet, H. C. (2008) · Spine · doi:10.1097/brs.0b013e31815e3a10 · Cited by 2,009
GRADE guidelines: 5. Rating the quality of evidence—publication bias
Guyatt, G. H., Oxman, A. D., Montori, V., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Djulbegovic, B., Atkins, D., Falck-Ytter, Y., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.01.011 · Cited by 1,819
Chapter 3 European guidelines for the management of acute nonspecific low back pain in primary care
van Tulder, M., Becker, A., Bekkering, T., Breen, A., del Real, M. T. G., Hutchinson, A., Koes, B., Laerum, E., Malmivaara, A., & On behalf of the COST B13 Working Group on Guidelines for the Management of Acute Low Back Pain in Primary Care (2006) · European Spine Journal · doi:10.1007/s00586-006-1071-2 · Cited by 1,258
2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group
Furlan, A. D., Malmivaara, A., Chou, R., Maher, C. G., Deyo, R. A., Schoene, M., Bronfort, G., & van Tulder, M. W. (2015) · Spine · doi:10.1097/brs.0000000000001061 · Cited by 704
Self-citationGraham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Machado, G. C., Maher, C. G., Ferreira, P. H., Pinheiro, M. B., Lin, C.-W. C., Day, R. O., McLachlan, A. J., & Ferreira, M. L. (2015) · BMJ · doi:10.1136/bmj.h1225 · Cited by 580
Self-citation
Cited by
Oliveira, C. B., Maher, C. G., Pinto, R. Z., Traeger, A. C., Lin, C.-W. C., Chenot, J.-F., van Tulder, M., & Koes, B. W. (2018) · European Spine Journal · doi:10.1007/s00586-018-5673-2 · Cited by 1,584
Self-citationChou, R., Deyo, R., Friedly, J., Skelly, A., Weimer, M., Fu, R., Dana, T., Kraegel, P., Griffin, J., & Grusing, S. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2458 · Cited by 864
Diagnosis and Management of Lumbar Spinal Stenosis: A Review
Katz, J. N., Zimmerman, Z. E., Mass, H., & Makhni, M. C. (2022) · JAMA · doi:10.1001/jama.2022.5921 · Cited by 562
Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care
Tick, H., Nielsen, A., Pelletier, K. R., Bonakdar, R., Simmons, S., Glick, R., Ratner, E., Lemmon, R. L., Wayne, P., & Zador, V. (2018) · EXPLORE · doi:10.1016/j.explore.2018.02.001 · Cited by 380
Management of functional somatic syndromes and bodily distress
Henningsen, P., Zipfel, S., Sattel, H., & Creed, F. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000484413 · Cited by 335
Long‐term adverse effects of paracetamol – a review
McCrae, J. C., Morrison, E. E., MacIntyre, I. M., Dear, J. W., & Webb, D. J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13656 · Cited by 308
Chiarotto, A., & Koes, B. W. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2032396 · Cited by 264
Paracetamol use during pregnancy — a call for precautionary action
Bauer, A. Z., Swan, S. H., Kriebel, D., Liew, Z., Taylor, H. S., Bornehag, C.-G., Andrade, A. M., Olsen, J., Jensen, R. H., Mitchell, R. T., et al. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00553-7 · Cited by 228
Paracetamol: A Review of Guideline Recommendations
Freo, U., Ruocco, C., Valerio, A., Scagnol, I., & Nisoli, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153420 · Cited by 208
Primary care management of non-specific low back pain: key messages from recent clinical guidelines
Almeida, M., Saragiotto, B., Richards, B., & Maher, C. G. (2018) · Medical Journal of Australia · doi:10.5694/mja17.01152 · Cited by 174
Self-citationPrenatal paracetamol exposure and child neurodevelopment: A review
Bauer, A. Z., Kriebel, D., Herbert, M. R., Bornehag, C.-G., & Swan, S. H. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.01.003 · Cited by 127
The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews
Abdel Shaheed, C., Ferreira, G. E., Dmitritchenko, A., McLachlan, A. J., Day, R. O., Saragiotto, B., Lin, C., Langendyk, V., Stanaway, F., Latimer, J., et al. (2021) · Medical Journal of Australia · doi:10.5694/mja2.50992 · Cited by 110
Self-citationDay, M. A., Ward, L. C., Ehde, D. M., Thorn, B. E., Burns, J., Barnier, A., Mattingley, J. B., & Jensen, M. P. (2019) · Pain Medicine · doi:10.1093/pm/pny273 · Cited by 91
Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial
MacIntyre, I. M., Turtle, E. J., Farrah, T. E., Graham, C., Dear, J. W., Webb, D. J., McCallum, M., Melville, V., Fok, H., McCrae, J. C., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056015 · Cited by 80
“They had to either be: (1) treated for hypertension with an average daytime ambulatory BP of <150/95 mm Hg on stable doses of ≥1 antihypertensive medication; or (2) untreated with an average daytime ambulatory BP ≥135/85 mm Hg but <150/95 mm Hg.”
BackgroundA Comprehensive Review of Over the Counter Treatment for Chronic Low Back Pain
Peck, J., Urits, I., Peoples, S., Foster, L., Malla, A., Berger, A. A., Cornett, E. M., Kassem, H., Herman, J., Kaye, A. D., et al. (2021) · Pain and Therapy · doi:10.1007/s40122-020-00209-w · Cited by 65
“However, the most updated Cochrane review concluded that acetaminophen, specifically 4 g per day, was not better than placebo in relieving acute LBP or improving quality of life and sleep quality in the short or long term [11].”
BackgroundSharma, S., Jensen, M. P., Moseley, G. L., & Abbott, J. H. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022423 · Cited by 33
Pickering, G., Creveaux, I., Macian, N., & Pereira, B. (2020) · Pain Medicine · doi:10.1093/pm/pnz037 · Cited by 23
Mörttinen-Vallius, H., Hartikainen, S., Seinelä, L., & Jämsen, E. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01627-8 · Cited by 10
Pickering, G., Mezouar, L., Kechemir, H., & Ebel-Bitoun, C. (2022) · JMIR Public Health and Surveillance · doi:10.2196/37790 · Cited by 9
“Additionally, a meta-analysis review that included 1785 cases reported that paracetamol did not produce better outcomes than placebo for patients with LBP, including for scores of sleep, quality of life, or physical function [57].”
Metadata
- Authors
- Saragiotto, B. T., Machado, G. C., Ferreira, M. L., Pinheiro, M. B., Abdel Shaheed, C., & Maher, C. G.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-06-06
- Volume
- 2019
- Issue
- 1
- Pages
- CD012230-CD012230
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2418120661
- Cited by
- 215
- References
- 15
- FWCI
- 17.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.